과제정보
Funding for this paper was provided by Namseoul University year 2023.
참고문헌
- Adam F, Kauskot A, Nurden P, Sulpice E, Hoylaerts MF, Davis RJ. Platelet JNK1 is involved in secretion and thrombus formation. Blood. 2010. 115: 4083-4092. https://doi.org/10.1182/blood-2009-07-233932
- Barrett NE, Holbrook L, Jones S, Kaiser WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B, Gibbins JM. Future innovations in anti-platelet therapies. Br J Pharmacol. 2008. 154: 918-939. https://doi.org/10.1038/bjp.2008.151
- Bassand JP. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk. Int J Cardiol. 2013. 163: 5-18. https://doi.org/10.1016/j.ijcard.2011.10.104
- Bugaud F, Nadal-Wollbold F, Levy-Toledano S, Rosa JP, Bryckaert M. Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood. 1999. 94: 3800-3805. https://doi.org/10.1182/blood.V94.11.3800
- Calderwood DA. Integrin activation. J Cell Sci. 2004. 117: 657-666. https://doi.org/10.1242/jcs.01014
- Chuang WY, Kung PH, Kuo CY, Wu CC. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidy-linositol 3-kinase/Akt pathway. Thromb Haemost. 2013. 109: 1120-1130. https://doi.org/10.1160/TH12-09-0636
- Das SS, Nanda GG, Alone DP. Artemisinin and curcumin inhibit Drosophila brain tumor, prolong life span, and restore locomotor activity. IUBMB Life. 2014. 66: 496-506. https://doi.org/10.1002/iub.1284
- Fang J, Zhao X, Li S, Xing X, Wang H, Lazarovici P, et al. Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90(rsk)-CREB pathway. Stem Cell Research & Therapy. 2019. 10: 312.
- Flevaris P, Li Z, Zhang G, Zheng Y, Liu J, Du X. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood. 2009. 113: 893-901. https://doi.org/10.1182/blood-2008-05-155978
- Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem. 1995. 270: 27395-27398. https://doi.org/10.1074/jbc.270.46.27395
- Lee DS, Kim TH, Jung YS. Inhibitory effect of allyl isothiocyanate on platelet aggregation. J Agric Food Chem. 2014. 62: 7131-7139. https://doi.org/10.1021/jf4041518
- Nadal-Wollbold F, Pawlowski M, Levy-Toledano S, Berrou E, Rosa JP, Bryckaert M. Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 2002. 531: 475-482. https://doi.org/10.1016/S0014-5793(02)03587-1
- Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994. 330: 1287-1294. https://doi.org/10.1056/NEJM199405053301808
- Peng T, Li S, Liu L, Yang C, Farhan M, Chen L, Su Q, Zheng W. Artemisinin attenuated ischemic stroke induced cell apoptosis through activation of ERK1/2/CREB/BCL-2 signaling pathway in vitro and in vivo. Int J Biol Sci. 2022. 18: 4578-4594. https://doi.org/10.7150/ijbs.69892
- Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002. 8: 1227-1234. https://doi.org/10.1038/nm1102-1227
- Vaiyapuri S, Ali MS, Moraes LA, Sage T, Lewis KR, Jones CI, Gibbins JM. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. Arterioscler Thromb Vasc Biol. 2013. 33: 2740-2749. https://doi.org/10.1161/ATVBAHA.113.301988
- Wang KS, Li J, Wang Z, Mi C, Ma J, Piao LX, et al. Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways. Immunopharmacol Immunotoxicol. 2017. 39: 28-36. https://doi.org/10.1080/08923973.2016.1267744
- Wong YK, Xu C, Kalesh KA, He Y, Lin Q, Wong WSF. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action. Med Res Rev. 2017. 37: 1492-1517. https://doi.org/10.1002/med.21446
- Xia Q, Wang X, Xu DJ, Chen XH, Chen FH. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential Oil. Thromb Res. 2012. 130: 409-414. https://doi.org/10.1016/j.thromres.2012.04.005
- Xu G, Huang YL, Li PL, Guo HM, Han XP. Neuroprotective effects of artemisinin against isoflurane-induced cognitive impairments and neuronal cell death involve JNK/ERK1/2 signalling and improved hippocampal histone acetylation in neonatal rats. The Journal of Pharmacy and Pharmacology. 2017. 69: 684-697. https://doi.org/10.1111/jphp.12704
- Yao Y, Guo Q, Cao Y, Qiu Y, Tan R, Yu Z. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res. 2018. 37: 282.
- Zeng Z, Xu J, Zheng W. Artemisinin protects PC12 cells against beta-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. 2017. 12: 625-633. https://doi.org/10.1016/j.redox.2017.04.003
- Zhao X, Fang J, Li S, Gaur U, Xing X, Wang H. Artemisinin Attenuated Hydrogen Peroxide (H2O2)-Induced Oxidative Injury in SH-SY5Y and Hippocampal Neurons via the Activation of AMPK Pathway. Int J Mol Sci. 2019. 20: 2680.